Fund Overview of SBI Healthcare Opportunities Fund-idcw
-
₹4,063.6 CrAUM
-
₹268.59NAV
-
1.89%Expense Ratio
-
EquityFund Category
Minimum amount you can invest: ₹500
Maximum amount you can invest: ₹1,00,000
We have used a return rate of 15% for our calculations.
Returns of SBI Healthcare Opportunities Fund-idcw
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 5.75% | NA | 6.12% |
| 6 Months | -2.63% | NA | 12.92% |
| 1 Year | 0.47% | 0.47% | 6.04% |
| 2 Years | 24.07% | 11.39% | 24.93% |
| 3 Years | 90.85% | 24.04% | 25.71% |
| 5 Years | 102.50% | 15.16% | 19.91% |
| 7 Years | 250.74% | 19.63% | NA |
| 10 Years | 207.85% | 11.90% | 12.78% |
Asset Allocation
equities
98.16%debt instruments
0.07%other assets or cash equivalents
1.77%SBI Healthcare Opportunities Fund-idcw is one Equity mutual fund offered by SBI Mutual Fund. Launched on 05 Jul 1999, the fund aims Long term capital appreciation. Equity investments in stocks of companies in the healthcare sector. It manages assets worth ₹4,063.6 crore as on Tue Mar 31, 2026. The expense ratio stands at 1.89%. Fund Manager Manager Education Fund Manager Manager EducationAbout SBI Healthcare Opportunities Fund-idcw
The portfolio allocation consists of 98.16% in equities, 0.07% in debt instruments, 1.77% in other assets or cash equivalents.Managed by Tanmaya Desai, it has delivered a return of 0.47% in the last year, a total return since inception of 16.13%.
People planning wealth creation often analyze the which sip is best in order to create sustainable wealth.
Key Metrics of SBI Healthcare Opportunities Fund-idcw
-
Standard Deviation14.71%
-
Sharpe Ratio1.15%
-
Alpha1.78%
-
Beta0.85%
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,293 | 6.92% | 6.81% | 8.05% | 28.30% | 17.27% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,293 | 6.92% | 6.81% | 8.05% | 28.30% | 17.27% |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,064 | 2.35% | 6.02% | 1.50% | 25.34% | 16.38% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹4,064 | 2.35% | 6.02% | 1.50% | 25.34% | 16.38% |
| Mirae Asset Healthcare Fund Direct-growth |
₹2,754 | 5.23% | 11.59% | 12.13% | 26.23% | 16.38% |
| Mirae Asset Healthcare Fund Direct-idcw |
₹2,754 | 5.23% | 11.59% | 12.13% | 26.23% | 16.38% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,293 | 6.85% | 6.60% | 7.16% | 27.21% | 16.24% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,293 | 6.85% | 6.60% | 7.16% | 27.21% | 16.24% |
| UTI Healthcare Fund Direct-growth |
₹1,056 | 6.27% | 8.90% | 9.88% | 26.44% | 15.34% |
| UTI Healthcare Fund Direct-idcw |
₹1,056 | 6.27% | 8.90% | 9.88% | 26.44% | 15.34% |
More funds from SBI Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
SBI Healthcare Opportunities Fund-growth
|
₹4,064 | 2.26% | 5.75% | -2.63% | 0.47% | 24.04% |
|
SBI Healthcare Opportunities Fund Direct Plan-growth
|
₹4,064 | 2.35% | 6.02% | -2.14% | 1.50% | 25.34% |
|
SBI Healthcare Opportunities Fund Direct Plan-idcw
|
₹4,064 | 2.35% | 6.02% | -2.14% | 1.50% | 25.34% |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Nippon India Pharma Fund-growth |
₹7,898 | ₹517.71 | 22.49% | 13.74% | 14.44% |
| Nippon India Pharma Fund Direct-growth |
₹7,898 | ₹580.66 | 23.59% | 14.77% | 15.46% |
| Nippon India Pharma Fund-idcw |
₹7,898 | ₹111.80 | 22.49% | 13.74% | 14.44% |
| Nippon India Pharma Fund Direct-idcw |
₹7,898 | ₹158.92 | 23.59% | 14.77% | 15.46% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,293 | ₹39.76 | 27.21% | 16.24% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,293 | ₹43.11 | 28.30% | 17.27% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,293 | ₹23.19 | 27.21% | 16.24% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,293 | ₹26.03 | 28.30% | 17.27% | - |
| SBI Healthcare Opportunities Fund-growth |
₹4,064 | ₹426.36 | 24.04% | 15.16% | 11.90% |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,064 | ₹492.05 | 25.34% | 16.38% | 13.14% |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.97% | ₹494.53 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.11% | ₹492.02 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.64% | ₹464.32 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.18% | ₹456.49 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.18% | ₹456.49 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.65% | ₹434.25 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.86% | ₹430.52 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.94% | ₹430.46 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.02% | ₹382.87 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.55% | ₹307.61 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.26% | ₹296.47 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.26% | ₹296.47 Cr |
| Divi's Laboratories Ltd | Healthcare | 6.90% | ₹284.99 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.05% | ₹281.27 Cr |
| Divi's Laboratories Ltd | Healthcare | 6.81% | ₹269.79 Cr |
| Divi's Laboratories Ltd | Healthcare | 6.59% | ₹267.62 Cr |
| Divi's Laboratories Ltd | Healthcare | 6.96% | ₹266.24 Cr |
| Divi's Laboratories Ltd | Healthcare | 6.36% | ₹250.34 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.12% | ₹242.40 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.76% | ₹234.65 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.63% | ₹232.56 Cr |
| Ami Organics Ltd | Healthcare | 5.67% | ₹230.27 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.62% | ₹229.56 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.62% | ₹229.56 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.67% | ₹222.94 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.48% | ₹222.57 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.24% | ₹209.02 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.46% | ₹208.82 Cr |
| Max Healthcare Institute Ltd | Healthcare | 4.97% | ₹202.08 Cr |
| Max Healthcare Institute Ltd | Healthcare | 4.82% | ₹196.55 Cr |
| Ami Organics Ltd | Healthcare | 4.77% | ₹194.29 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.01% | ₹191.36 Cr |
| Cipla Ltd | Healthcare | 4.81% | ₹190.73 Cr |
| Cipla Ltd | Healthcare | 4.45% | ₹183.76 Cr |
| Lupin Ltd | Healthcare | 4.73% | ₹180.84 Cr |
| Cipla Ltd | Healthcare | 4.59% | ₹180.40 Cr |
| Cipla Ltd | Healthcare | 4.41% | ₹180.16 Cr |
| Cipla Ltd | Healthcare | 4.41% | ₹180.16 Cr |
| Repo | Unspecified | 4.30% | ₹177.72 Cr |
| Lupin Ltd | Healthcare | 4.44% | ₹177.20 Cr |
| Lupin Ltd | Healthcare | 4.23% | ₹174.90 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.25% | ₹173.33 Cr |
| Lupin Ltd | Healthcare | 4.23% | ₹172.64 Cr |
| Ami Organics Ltd | Healthcare | 4.50% | ₹172.13 Cr |
| Repo | Unspecified | 4.32% | ₹171.15 Cr |
| Lonza Group Ag | Healthcare | 4.24% | ₹168.03 Cr |
| Lupin Ltd | Healthcare | 4.10% | ₹166.60 Cr |
| Lonza Group Ag | Healthcare | 4.01% | ₹165.52 Cr |
| Ami Organics Ltd | Healthcare | 4.00% | ₹165.38 Cr |
| Lonza Group Ag | Healthcare | 4.05% | ₹165.22 Cr |
| Lonza Group Ag | Healthcare | 4.05% | ₹165.22 Cr |
| Lupin Ltd | Healthcare | 4.04% | ₹164.93 Cr |
| Lupin Ltd | Healthcare | 4.04% | ₹164.93 Cr |
| Repo | Unspecified | 4.02% | ₹164.26 Cr |
| Repo | Unspecified | 4.02% | ₹164.26 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.96% | ₹160.80 Cr |
| Lupin Ltd | Healthcare | 4.08% | ₹160.55 Cr |
| Lonza Group Ag | Healthcare | 4.06% | ₹159.76 Cr |
| Lupin Ltd | Healthcare | 4.02% | ₹159.17 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.14% | ₹158.43 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.85% | ₹157.10 Cr |
| Ami Organics Ltd | Healthcare | 3.81% | ₹155.49 Cr |
| Ami Organics Ltd | Healthcare | 3.81% | ₹155.49 Cr |
| Laurus Labs Ltd | Healthcare | 3.89% | ₹155.12 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.86% | ₹154.00 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.76% | ₹153.46 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.76% | ₹153.46 Cr |
| Ami Organics Ltd | Healthcare | 3.85% | ₹153.44 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.74% | ₹151.93 Cr |
| Repo | Unspecified | 3.85% | ₹151.45 Cr |
| Cipla Ltd | Healthcare | 3.79% | ₹151.13 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.60% | ₹148.82 Cr |
| Biocon Ltd | Healthcare | 3.59% | ₹146.18 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.70% | ₹145.47 Cr |
| Lonza Group Ag | Healthcare | 3.63% | ₹145.00 Cr |
| Aether Industries Ltd | Materials | 3.56% | ₹144.47 Cr |
| Laurus Labs Ltd | Healthcare | 3.50% | ₹144.39 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.66% | ₹144.13 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.49% | ₹142.40 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.49% | ₹142.40 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.59% | ₹142.39 Cr |
| Laurus Labs Ltd | Healthcare | 3.48% | ₹142.01 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 3.46% | ₹141.42 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 3.46% | ₹141.42 Cr |
| Aether Industries Ltd | Materials | 3.67% | ₹140.28 Cr |
| Repo | Unspecified | 3.51% | ₹139.84 Cr |
| Gland Pharma Ltd | Healthcare | 3.54% | ₹139.41 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.49% | ₹138.40 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.34% | ₹137.87 Cr |
| Biocon Ltd | Healthcare | 3.60% | ₹137.55 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.35% | ₹136.77 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.35% | ₹136.77 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.45% | ₹136.73 Cr |
| Repo | Unspecified | 3.36% | ₹136.55 Cr |
| Biocon Ltd | Healthcare | 3.33% | ₹135.34 Cr |
| Gland Pharma Ltd | Healthcare | 3.31% | ₹135.02 Cr |
| Gland Pharma Ltd | Healthcare | 3.31% | ₹135.02 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.25% | ₹134.22 Cr |
| Aether Industries Ltd | Materials | 3.29% | ₹134.20 Cr |
| Laurus Labs Ltd | Healthcare | 3.27% | ₹133.51 Cr |
| Laurus Labs Ltd | Healthcare | 3.27% | ₹133.51 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.47% | ₹132.52 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 3.21% | ₹132.40 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.24% | ₹131.97 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.34% | ₹131.53 Cr |
| Gland Pharma Ltd | Healthcare | 3.31% | ₹131.01 Cr |
| Repo | Unspecified | 3.19% | ₹129.96 Cr |
| Anthem Biosciences Ltd. | Healthcare | 3.17% | ₹128.76 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.15% | ₹128.74 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.15% | ₹128.74 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.16% | ₹128.37 Cr |
| Biocon Ltd | Healthcare | 3.09% | ₹127.47 Cr |
| Laurus Labs Ltd | Healthcare | 3.33% | ₹127.38 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.20% | ₹126.68 Cr |
| Ami Organics Ltd | Healthcare | 3.19% | ₹126.54 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.22% | ₹126.46 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.09% | ₹126.18 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.09% | ₹126.18 Cr |
| Lonza Group Ag | Healthcare | 3.09% | ₹126.12 Cr |
| Biocon Ltd | Healthcare | 3.16% | ₹126.05 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 3.20% | ₹126.04 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 3.14% | ₹125.41 Cr |
| Lonza Group Ag | Healthcare | 3.25% | ₹124.30 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.10% | ₹123.76 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.09% | ₹123.37 Cr |
| Gland Pharma Ltd | Healthcare | 2.98% | ₹123.17 Cr |
| Aether Industries Ltd | Materials | 2.97% | ₹122.81 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.12% | ₹122.53 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 3.18% | ₹121.61 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.94% | ₹121.55 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.98% | ₹121.37 Cr |
| Concord Biotech Ltd. | Healthcare | 3.06% | ₹121.08 Cr |
| Lonza Group Ag | Healthcare | 2.97% | ₹120.87 Cr |
| Aether Industries Ltd | Materials | 3.02% | ₹120.41 Cr |
| Abbott India Ltd | Healthcare | 2.91% | ₹120.30 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.03% | ₹120.21 Cr |
| Poly Medicure Ltd | Healthcare | 2.94% | ₹119.98 Cr |
| Poly Medicure Ltd | Healthcare | 2.94% | ₹119.98 Cr |
| Laurus Labs Ltd | Healthcare | 3.03% | ₹119.97 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.90% | ₹119.89 Cr |
| Fortis Healthcare Ltd | Healthcare | 2.93% | ₹119.25 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.12% | ₹119.21 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.92% | ₹119.21 Cr |
| Laurus Labs Ltd | Healthcare | 2.93% | ₹119.12 Cr |
| Biocon Ltd | Healthcare | 2.92% | ₹119.07 Cr |
| Biocon Ltd | Healthcare | 2.92% | ₹119.07 Cr |
| Concord Biotech Ltd. | Healthcare | 3.02% | ₹118.63 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.97% | ₹118.61 Cr |
| Ami Organics Ltd | Healthcare | 3.02% | ₹118.60 Cr |
| Poly Medicure Ltd | Healthcare | 2.98% | ₹118.19 Cr |
| Laurus Labs Ltd | Healthcare | 3.00% | ₹117.85 Cr |
| Abbott India Ltd | Healthcare | 2.98% | ₹117.16 Cr |
| Poly Medicure Ltd | Healthcare | 2.97% | ₹116.89 Cr |
| Poly Medicure Ltd | Healthcare | 2.82% | ₹116.35 Cr |
| Abbott India Ltd | Healthcare | 2.91% | ₹116.10 Cr |
| Abbott India Ltd | Healthcare | 2.84% | ₹115.98 Cr |
| Abbott India Ltd | Healthcare | 2.84% | ₹115.98 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.84% | ₹115.31 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.90% | ₹114.83 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.00% | ₹114.70 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.75% | ₹113.70 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.79% | ₹113.56 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.97% | ₹113.55 Cr |
| Abbott India Ltd | Healthcare | 2.86% | ₹113.33 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.77% | ₹112.79 Cr |
| Biocon Ltd | Healthcare | 2.81% | ₹111.47 Cr |
| Gland Pharma Ltd | Healthcare | 2.90% | ₹110.80 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.70% | ₹110.13 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.70% | ₹110.13 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.76% | ₹110.13 Cr |
| Anthem Biosciences Ltd. | Healthcare | 2.68% | ₹109.38 Cr |
| Gland Pharma Ltd | Healthcare | 2.68% | ₹109.33 Cr |
| Biocon Ltd | Healthcare | 2.77% | ₹109.12 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.76% | ₹108.50 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.67% | ₹106.51 Cr |
| Poly Medicure Ltd | Healthcare | 2.67% | ₹106.42 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.68% | ₹106.07 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.61% | ₹105.98 Cr |
| Aether Industries Ltd | Materials | 2.58% | ₹105.52 Cr |
| Aether Industries Ltd | Materials | 2.58% | ₹105.52 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.68% | ₹105.49 Cr |
| Aether Industries Ltd | Materials | 2.68% | ₹105.27 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.57% | ₹104.35 Cr |
| Concord Biotech Ltd. | Healthcare | 2.55% | ₹103.95 Cr |
| Concord Biotech Ltd. | Healthcare | 2.55% | ₹103.95 Cr |
| Gland Pharma Ltd | Healthcare | 2.59% | ₹103.32 Cr |
| Aether Industries Ltd | Materials | 2.60% | ₹103.05 Cr |
| Concord Biotech Ltd. | Healthcare | 2.47% | ₹102.07 Cr |
| Gland Pharma Ltd | Healthcare | 2.50% | ₹101.77 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.45% | ₹99.44 Cr |
| Anthem Biosciences Ltd. | Healthcare | 2.48% | ₹98.17 Cr |
| Poly Medicure Ltd | Healthcare | 2.55% | ₹97.34 Cr |
| Concord Biotech Ltd. | Healthcare | 2.43% | ₹96.88 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.53% | ₹96.60 Cr |
| Abbott India Ltd | Healthcare | 2.52% | ₹96.48 Cr |
| Anthem Biosciences Ltd. | Healthcare | 2.32% | ₹91.34 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.24% | ₹90.92 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.21% | ₹90.41 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.21% | ₹90.41 Cr |
| Concord Biotech Ltd. | Healthcare | 2.16% | ₹87.88 Cr |
| Sudeep Pharma Ltd. | 2.13% | ₹86.90 Cr | |
| Aurobindo Pharma Ltd | Healthcare | 2.08% | ₹85.87 Cr |
| Anthem Biosciences Ltd. | Healthcare | 2.09% | ₹85.21 Cr |
| Anthem Biosciences Ltd. | Healthcare | 2.09% | ₹85.21 Cr |
| Anthem Biosciences Ltd. | Healthcare | 2.12% | ₹84.70 Cr |
| Concord Biotech Ltd. | Healthcare | 2.21% | ₹84.61 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.21% | ₹84.54 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.07% | ₹84.15 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 2.12% | ₹84.12 Cr |
| Anthem Biosciences Ltd. | Healthcare | 2.19% | ₹83.90 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.08% | ₹82.81 Cr |
| Anthem Biosciences Ltd. | Healthcare | 2.00% | ₹82.51 Cr |
| Sudeep Pharma Ltd. | 2.14% | ₹81.74 Cr | |
| Sudeep Pharma Ltd. | 1.98% | ₹80.59 Cr | |
| Poly Medicure Ltd | Healthcare | 1.97% | ₹80.39 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.96% | ₹79.86 Cr |
| Aurobindo Pharma Ltd | Healthcare | 1.95% | ₹79.72 Cr |
| Aurobindo Pharma Ltd | Healthcare | 1.95% | ₹79.72 Cr |
| Abbott India Ltd | Healthcare | 1.95% | ₹79.59 Cr |
| Abbott India Ltd | Healthcare | 1.91% | ₹77.75 Cr |
| Sudeep Pharma Ltd. | 1.92% | ₹76.78 Cr | |
| Poly Medicure Ltd | Healthcare | 1.88% | ₹76.23 Cr |
| Aurobindo Pharma Ltd | Healthcare | 1.93% | ₹75.87 Cr |
| Ajanta Pharma Ltd | Healthcare | 1.84% | ₹74.85 Cr |
| Concord Biotech Ltd. | Healthcare | 1.80% | ₹73.32 Cr |
| Aurobindo Pharma Ltd | Healthcare | 1.82% | ₹71.95 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.78% | ₹70.45 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.64% | ₹67.73 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.60% | ₹63.66 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.59% | ₹63.43 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.53% | ₹60.47 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.53% | ₹60.00 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.45% | ₹59.88 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.45% | ₹59.32 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.45% | ₹59.32 Cr |
| Pfizer Ltd | Healthcare | 1.28% | ₹52.09 Cr |
| Pfizer Ltd | Healthcare | 1.28% | ₹52.09 Cr |
| Pfizer Ltd | Healthcare | 1.30% | ₹51.56 Cr |
| Pfizer Ltd | Healthcare | 1.28% | ₹50.36 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.31% | ₹50.11 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.27% | ₹50.02 Cr |
| Pfizer Ltd | Healthcare | 1.25% | ₹49.88 Cr |
| Pfizer Ltd | Healthcare | 1.20% | ₹49.75 Cr |
| Nephrocare Health Services Ltd. | 1.17% | ₹47.50 Cr | |
| Suven Pharmaceuticals Ltd | Healthcare | 1.20% | ₹45.76 Cr |
| Pfizer Ltd | Healthcare | 1.19% | ₹45.64 Cr |
| Nephrocare Health Services Ltd. | 1.10% | ₹42.22 Cr | |
| Nephrocare Health Services Ltd. | 1.00% | ₹40.55 Cr | |
| Medplus Health Services Ltd | Healthcare | 0.98% | ₹40.44 Cr |
| Medplus Health Services Ltd | Healthcare | 1.01% | ₹40.37 Cr |
| Medplus Health Services Ltd | Healthcare | 1.05% | ₹39.95 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.98% | ₹38.89 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.00% | ₹38.35 Cr |
| Repo | Unspecified | 1.00% | ₹38.22 Cr |
| Medplus Health Services Ltd | Healthcare | 0.93% | ₹38.14 Cr |
| Medplus Health Services Ltd | Healthcare | 0.93% | ₹38.14 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.91% | ₹37.19 Cr |
| Nephrocare Health Services Ltd. | 0.92% | ₹36.81 Cr | |
| Gufic Biosciences Ltd | Healthcare | 0.93% | ₹36.70 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.89% | ₹36.32 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.89% | ₹36.32 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.89% | ₹36.17 Cr |
| Gufic Biosciences Ltd | Healthcare | 0.86% | ₹35.57 Cr |
| Gufic Biosciences Ltd | Healthcare | 0.90% | ₹35.45 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.90% | ₹35.40 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.85% | ₹34.95 Cr |
| Medplus Health Services Ltd | Healthcare | 0.87% | ₹34.21 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.85% | ₹33.90 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.83% | ₹33.67 Cr |
| Gufic Biosciences Ltd | Healthcare | 0.84% | ₹33.60 Cr |
| Gufic Biosciences Ltd | Healthcare | 0.80% | ₹32.54 Cr |
| Gufic Biosciences Ltd | Healthcare | 0.80% | ₹32.54 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.83% | ₹31.85 Cr |
| Gufic Biosciences Ltd | Healthcare | 0.80% | ₹30.73 Cr |
| Sudeep Pharma Ltd. | 0.72% | ₹29.82 Cr | |
| Gufic Biosciences Ltd | Healthcare | 0.69% | ₹28.19 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 0.67% | ₹27.39 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 0.67% | ₹27.39 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.63% | ₹25.79 Cr |
| Medplus Health Services Ltd | Healthcare | 0.62% | ₹25.43 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 0.62% | ₹25.11 Cr |
| Gufic Biosciences Ltd | Healthcare | 0.54% | ₹21.90 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 0.53% | ₹21.54 Cr |
| Corona Remedies Ltd. | 0.51% | ₹20.37 Cr | |
| Medplus Health Services Ltd | Healthcare | 0.41% | ₹16.80 Cr |
| Corona Remedies Ltd. | 0.39% | ₹15.87 Cr | |
| Pfizer Ltd | Healthcare | 0.37% | ₹15.19 Cr |
| Corona Remedies Ltd. | 0.39% | ₹14.79 Cr | |
| Net Receivables | Unspecified | 0.39% | ₹14.47 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 0.35% | ₹14.31 Cr |
| Corona Remedies Ltd. | 0.29% | ₹11.67 Cr | |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 0.13% | ₹5.01 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 0.12% | ₹4.86 Cr |
| Government Of India 36005 182 Days Tbill 20nv25 Fv Rs 100 | Financial | 0.07% | ₹2.99 Cr |
| Government Of India 36005 182 Days Tbill 20nv25 Fv Rs 100 | Financial | 0.07% | ₹2.99 Cr |
| Government Of India 36005 182 Days Tbill 20nv25 Fv Rs 100 | Financial | 0.08% | ₹2.98 Cr |
| Medplus Health Services Ltd | Healthcare | 0.08% | ₹2.97 Cr |
| Government Of India 36005 182 Days Tbill 20nv25 Fv Rs 100 | Financial | 0.07% | ₹2.96 Cr |
| Government Of India 36714 364 Days Tbill 19nv26 Fv Rs 100 | Financial | 0.07% | ₹2.90 Cr |
| Government Of India 36714 364 Days Tbill 19nv26 Fv Rs 100 | Financial | 0.07% | ₹2.89 Cr |
| Government Of India 36714 364 Days Tbill 19nv26 Fv Rs 100 | Financial | 0.08% | ₹2.87 Cr |
| Government Of India 36714 364 Days Tbill 19nv26 Fv Rs 100 | Financial | 0.07% | ₹2.86 Cr |
| Government Of India 36714 364 Days Tbill 19nv26 Fv Rs 100 | Financial | 0.07% | ₹2.85 Cr |
| Net Payables | Unspecified | -0.14% | ₹-6.73 Cr |
| Net Payables | Unspecified | -0.14% | ₹-6.73 Cr |
| Net Payables | Unspecified | -0.17% | ₹-7.04 Cr |
| Net Payables | Unspecified | -0.19% | ₹-7.84 Cr |
| Net Payables | Unspecified | -0.26% | ₹-10.33 Cr |
| Net Payables | Unspecified | -0.29% | ₹-11.35 Cr |
| Net Payables | Unspecified | -0.58% | ₹-21.60 Cr |
| Net Payables | Unspecified | -1.59% | ₹-64.42 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹43.11 | 28.30% | 17.27% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹26.03 | 28.30% | 17.27% | - |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹492.05 | 25.34% | 16.38% | - |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹341.86 | 25.34% | 16.38% | - |
| Mirae Asset Healthcare Fund Direct-growth |
₹45.41 | 26.23% | 16.38% | - |
| Mirae Asset Healthcare Fund Direct-idcw |
₹27.35 | 26.23% | 16.38% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹39.76 | 27.21% | 16.24% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹23.19 | 27.21% | 16.24% | - |
| UTI Healthcare Fund Direct-growth |
₹331.99 | 26.44% | 15.34% | - |
| UTI Healthcare Fund Direct-idcw |
₹256.60 | 26.44% | 15.34% | - |
Frequently Asked Questions
SBI Healthcare Opportunities Fund-idcw
What is the current AUM of SBI Healthcare Opportunities Fund-idcw?
As of Tue Mar 31, 2026, SBI Healthcare Opportunities Fund-idcw manages assets worth ₹4,063.6 crore
How has SBI Healthcare Opportunities Fund-idcw performed recently?
- 3 Months: 5.75%
- 6 Months: -2.63%
What is the long-term performance of SBI Healthcare Opportunities Fund-idcw?
- 3 Years CAGR: 24.04%
- 5 Years CAGR: 15.16%
- Since Inception: 16.13%
What is the portfolio composition of SBI Healthcare Opportunities Fund-idcw?
Equity: 98.16%, Debt: 0.07%, Others: 1.77%.
Who manages SBI Healthcare Opportunities Fund-idcw?
SBI Healthcare Opportunities Fund-idcw is managed by Tanmaya Desai from SBI Mutual Fund.
What is the market-cap allocation of SBI Healthcare Opportunities Fund-idcw?
Large Cap: 36.53%, Mid Cap: 27.21%, Small Cap: 36.26%.
Which are the top companies SBI Healthcare Opportunities Fund-idcw has invested in?
- Sun Pharmaceutical Industries Ltd – 11.97% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 12.11% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 11.64% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 11.18% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 11.18% of the fund's portfolio
Which are the major sectors SBI Healthcare Opportunities Fund-idcw focuses on?
- Healthcare – 829.14% of the fund's portfolio
- Unspecified – 28.60% of the fund's portfolio
- Materials – 26.95% of the fund's portfolio
- Other – 14.66% of the fund's portfolio
- Financial – 0.65% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.





